Telix stock: RBC keeps AUD 21.00 target for Telix stock

Published on 10/22/2026 at 21:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 revenue rose 19 percent on October 21, 2026. Telix stock costs EUR 8.64 on October 22, 2026, up 0.45 percent versus the Tradegate close.

Analyst target and reporting date

A report dated October 21, 2026 says RBC maintained an AUD 21.00 target for Telix.
Telix reported USD 245 million of third-quarter revenue on October 21, 2026, up 19 percent year over year.
Telix stock costs EUR 8.64 at Lang & Schwarz on October 22, 2026 at 9:29 p.m. CEST, 0.45 percent above the Tradegate close of October 22, 2026.
Telix expects fiscal-year 2026 revenue and other income to exceed USD 1 billion.

Telix, AU000000TLX2, Illustration mit AI erstellt.

RBC maintained an AUD 21.00 price target and Buy rating for Telix Pharmaceuticals on October 21, 2026, according to Markets Insider. Telix reported USD 245 million of third-quarter revenue, up 19 percent from the prior-year quarter, while the stock was at EUR 8.64 at Lang & Schwarz on October 22, 2026 at 9:29 p.m. CEST, 0.45 percent above the Tradegate close of October 22, 2026.

Revenue growth stays uneven

Telix Pharmaceuticals said on October 21, 2026 that Precision Medicine revenue reached USD 201 million in the third quarter, 30 percent above the prior-year quarter. Telix Manufacturing Solutions revenue fell 6 percent to USD 44 million, leaving total revenue 1 percent below the second quarter's USD 247 million.

ASX range sets the frame

The ASX quote stood at AUD 13.66 on October 22, 2026 at 4:12 p.m. AEDT, down 5.92 percent on the session. Telix's 52-week range was AUD 8.26 to AUD 18.22, and the stock was up 21.96 percent since the start of 2026. The market capitalization was AUD 4.6 billion.

Valuation and corporate dates

Telix carried a trailing price-to-earnings ratio of 106.55 on October 22, 2026, while its dividend yield was 0.00 percent. The company expects a general meeting of shareholders on December 1, 2026, in connection with its proposed ITM merger. The transaction includes upfront consideration of USD 1.65 billion and approximately USD 1.25 billion in Telix shares, according to the October 21 company update.

Guidance remains above USD 1 billion

Telix reaffirmed fiscal-year 2026 revenue and other income above USD 1 billion. Revenue is tracking toward the upper end of guidance of USD 950 million to USD 970 million plus USD 40 million of other income, while research and development spending guidance is USD 240 million to USD 260 million.

Stock and investor dates

The next significant date is the December 1, 2026 shareholder meeting. Telix's combination of 19 percent quarterly revenue growth and a 106.55 trailing price-to-earnings ratio leaves execution against the upper end of guidance as the central valuation reference.

Telix trades below its yearly high

Telix stock was trading at EUR 8.64 at Lang & Schwarz on October 22, 2026 at 9:29 p.m. CEST, 0.45 percent above the Tradegate close of October 22, 2026 at EUR 8.60. The further course of trading is shown by the continuously updated real-time quote of Telix stock.